Moderate Aplastic Anemia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Moderate Aplastic Anemia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT01137643

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in…

United States15,000 participantsStarted 2009-07

Treatment: biologic sample preservation procedure, cytology specimen collection procedure

All recent trials (48 shown)

Not Yet RecruitingPhase 2

NCT07558434

CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA

This study aimed to explore the efficacy and safety of cyclosporine (CsA) +eltrombopag (EPAG)/hetrombopag (HPAG)+romiplostim N01 in the treatment of newly-diag…

Location not specified43 participantsStarted 2026-04

Treatment: Cyclosporine (CsA), thrombopoietin receptor agonist (TPO-RA)

Not Yet RecruitingPhase 3

NCT07548671

Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA

This study aimed to compare the efficacy and safety of enarodustat combined with cyclosporine versus cyclosporine monotherapy in the treatment of newly-diagnose…

Location not specified90 participantsStarted 2026-04

Treatment: Enarodustat, Cyclosporine (CsA)

Moderate Aplastic Anemia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

All recent trials (48 shown)

CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA

Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

All recent trials (48 shown)

CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA

Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA

Eltrombopag for Moderate Aplastic Anemia

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA

Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignanci…

Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia

Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)

Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study

A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With Lusutrombopag

Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA

Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly

Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment…

Romiplostim in Combination With CsA vs. CsA in the Treatment of Newly Diagnosed NSAA

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for He…

Up-front Matched Unrelated Donor Transplantation in Pediatric Patients With Idiopathic Aplastic Anemia